Discover opportunities months before the RFP drops
Learn more →Key metrics and characteristics
The county where this buyer is located.
Postal code for this buyer's location.
How likely this buyer is to spend on new technology based on operating budget trends.
How likely this buyer is to adopt new AI technologies.
How often this buyer champions startups and early adoption.
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Active opportunities open for bidding
NAC Pharmaceuticals (36E797)
The Department of Veterans Affairs (NAC Pharmaceuticals) issued an award notice for Pregabalin Capsules under solicitation number 36E79725R0055. The contract, valued at over $14.5 million, was awarded to SCIEGEN PHARMACEUTICALS INC to provide 16 line items of pharmaceutical supplies. This federal procurement is managed by the VA National Acquisition Center located in Hines, Illinois.
Posted Date
Feb 11, 2026
Due Date
Apr 12, 2026
Release: Feb 11, 2026
NAC Pharmaceuticals (36E797)
Close: Apr 12, 2026
The Department of Veterans Affairs (NAC Pharmaceuticals) issued an award notice for Pregabalin Capsules under solicitation number 36E79725R0055. The contract, valued at over $14.5 million, was awarded to SCIEGEN PHARMACEUTICALS INC to provide 16 line items of pharmaceutical supplies. This federal procurement is managed by the VA National Acquisition Center located in Hines, Illinois.
AvailableNAC Pharmaceuticals (36E797)
The Department of Veterans Affairs National Acquisition Center intends to issue RFP 36E79726R0010 for an unrestricted procurement of Venlafaxine HCL 24-Hour Sustained Action capsules to supply VA (including CMOPs and State Veterans Homes) and other federal health programs. The presolicitation was posted Feb 5, 2026 and states the formal solicitation will be issued electronically on or about Feb 17, 2026 with a tentative closing date of Mar 3, 2026; offerors must provide exact product labeling and unique NDC numbers and meet specified packaging requirements. The procurement is for an estimated annual requirement totaling approximately 730,000 bottles across strengths and package sizes, and the contract will be one year with four one-year option periods (maximum five years), with distribution via VA and DoD Pharmaceutical Prime Vendor Programs.
Posted Date
Feb 5, 2026
Due Date
Mar 3, 2026
Release: Feb 5, 2026
NAC Pharmaceuticals (36E797)
Close: Mar 3, 2026
The Department of Veterans Affairs National Acquisition Center intends to issue RFP 36E79726R0010 for an unrestricted procurement of Venlafaxine HCL 24-Hour Sustained Action capsules to supply VA (including CMOPs and State Veterans Homes) and other federal health programs. The presolicitation was posted Feb 5, 2026 and states the formal solicitation will be issued electronically on or about Feb 17, 2026 with a tentative closing date of Mar 3, 2026; offerors must provide exact product labeling and unique NDC numbers and meet specified packaging requirements. The procurement is for an estimated annual requirement totaling approximately 730,000 bottles across strengths and package sizes, and the contract will be one year with four one-year option periods (maximum five years), with distribution via VA and DoD Pharmaceutical Prime Vendor Programs.
NAC Pharmaceuticals (36E797)
The Department of Veterans Affairs, National Acquisition Center (NAC) intends to issue RFP 36E79726R0012 for Montelukast Sodium chewable tablets to supply VA, DoD, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is an unrestricted commercial item acquisition under FAR Part 12 with one contract award expected, covering a one-year base period plus four one-year option periods and distribution via VA and DoD Pharmaceutical Prime Vendor Programs. The solicitation will be issued electronically on or about 2026-02-17 with a tentative closing date of 2026-03-03; all solicitation documents and amendments will be posted on SAM.gov and no paper copies will be provided.
Posted Date
Feb 5, 2026
Due Date
Mar 3, 2026
Release: Feb 5, 2026
NAC Pharmaceuticals (36E797)
Close: Mar 3, 2026
The Department of Veterans Affairs, National Acquisition Center (NAC) intends to issue RFP 36E79726R0012 for Montelukast Sodium chewable tablets to supply VA, DoD, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is an unrestricted commercial item acquisition under FAR Part 12 with one contract award expected, covering a one-year base period plus four one-year option periods and distribution via VA and DoD Pharmaceutical Prime Vendor Programs. The solicitation will be issued electronically on or about 2026-02-17 with a tentative closing date of 2026-03-03; all solicitation documents and amendments will be posted on SAM.gov and no paper copies will be provided.
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
Track vendor wins and renewal opportunities
NAC Pharmaceuticals (36E797)
BPA FOR PHOSPHOLINE IODIDE
Effective Date
Apr 17, 2024
Expires
Effective: Apr 17, 2024
NAC Pharmaceuticals (36E797)
Expires:
BPA FOR PHOSPHOLINE IODIDE
AvailableNAC Pharmaceuticals (36E797)
BLANKET PURCHASE AGREEMENT (BPA) FOR VISUDYNE AND XIPERE.
Effective Date
Oct 14, 2022
Expires
Effective: Oct 14, 2022
NAC Pharmaceuticals (36E797)
Expires:
BLANKET PURCHASE AGREEMENT (BPA) FOR VISUDYNE AND XIPERE.
AvailableNAC Pharmaceuticals (36E797)
BPA FOR MIPLYFFA AND OLPRUVA
Effective Date
Jul 8, 2025
Expires
Effective: Jul 8, 2025
NAC Pharmaceuticals (36E797)
Expires:
BPA FOR MIPLYFFA AND OLPRUVA
AvailableSee expiring contracts, renewal risk, pricing history, and competitor awards — then sync the data to your CRM.
Track NAC Pharmaceuticals (36E797)'s board meetings, strategic plans, and budget discussions. Identify opportunities 6-12 months before competitors see the RFP.
Keep your public sector contacts fresh and actionable. No more stale data.
Premium
Win more deals with deep buyer insights
Premium
Access the largest public sector contact database